These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30843635)
1. Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma. Jang JY; Kim DS; Park HY; Shin SC; Cha W; Lee JC; Wang SG; Lee BJ Head Neck; 2019 Aug; 41(8):2602-2609. PubMed ID: 30843635 [TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma. Yu XM; Lo CY; Lam AK; Leung P; Luk JM Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194 [TBL] [Abstract][Full Text] [Related]
3. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe. Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Chang HS; Park CS ANZ J Surg; 2019 Nov; 89(11):E498-E501. PubMed ID: 31566299 [TBL] [Abstract][Full Text] [Related]
4. Robotic-assisted modified radical neck dissection using a bilateral axillo-breast approach (robotic BABA MRND) for papillary thyroid carcinoma with lateral lymph node metastasis. Yu HW; Chai YJ; Kim SJ; Choi JY; Lee KE Surg Endosc; 2018 May; 32(5):2322-2327. PubMed ID: 29101559 [TBL] [Abstract][Full Text] [Related]
5. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma]. Qi ZJ; Liu LF; Cheng L; Han X; Wang T; Li F; Lu C; Zhang AB Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):603-606. PubMed ID: 31327195 [No Abstract] [Full Text] [Related]
6. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178 [TBL] [Abstract][Full Text] [Related]
7. [Value of VEGF-C, VEGF-D and VEGFR-3 levels combined with serum TSH in diagnosis of papillary thyroid carcinoma]. Huang J; Li Y; Xue G; Zhang W; Li S; Zhang J; Wu J Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1814-7, 1821. PubMed ID: 25537909 [TBL] [Abstract][Full Text] [Related]
8. Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma. Jin S; Bao W; Yang YT; Bai T; Bai Y Sci Rep; 2018 Nov; 8(1):17355. PubMed ID: 30478394 [TBL] [Abstract][Full Text] [Related]
9. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma. Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160 [TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma]. Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720 [TBL] [Abstract][Full Text] [Related]
11. Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound. Lee JH; Shin HJ; Yoon JH; Kim EK; Moon HJ; Lee HS; Kwon HJ; Kwak JY Head Neck; 2017 Feb; 39(2):334-340. PubMed ID: 27704649 [TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis. Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894 [TBL] [Abstract][Full Text] [Related]
13. Predictive factors of skip metastases to lateral neck compartment leaping central neck compartment in papillary thyroid carcinoma. Lim YC; Koo BS Oral Oncol; 2012 Mar; 48(3):262-5. PubMed ID: 22047924 [TBL] [Abstract][Full Text] [Related]
14. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237 [TBL] [Abstract][Full Text] [Related]
16. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study. Liu Y; Wang Y; Zhao K; Li D; Chen Z; Jiang R; Wang X; He X BMC Cancer; 2020 Mar; 20(1):181. PubMed ID: 32131769 [TBL] [Abstract][Full Text] [Related]
17. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma]. Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398 [TBL] [Abstract][Full Text] [Related]
18. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma. Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000 [TBL] [Abstract][Full Text] [Related]
19. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma. Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154 [TBL] [Abstract][Full Text] [Related]
20. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma. Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]